Farmakologiczne leczenie stwardnienia rozsianego w Tajlandii kosztuje zazwyczaj od $3,000 / 102,000฿ do $6,000 / 204,000฿. Ceny zależą od klasy leku, standardu kliniki oraz miasta. W Polsce podobne procedury kosztują średnio około $4,000 / 136,000฿. Tajlandia oferuje oszczędności rzędu 25%. Standardowy koszt obejmuje konsultację neurologiczną, podstawowe badania diagnostyczne oraz sam lek.
Opinia ekspercka Bookimed: Wybór placówki z akredytacją JCI, jak Bumrungrad International Hospital, gwarantuje dostęp do neurologii na wysokim poziomie. Pomimo marż szpitali prywatnych, pacjenci korzystają z technologii takich jak obrazowanie wspomagane sztuczną inteligencją. Kliniki w Phuket oferują procesy hodowli komórkowej uznawane przez NLEM. Połączenie zaawansowanych leków biologicznych i terapii wspomagających zapewnia wysoką jakość opieki w korzystnej cenie.
| Tajlandia | Turcja | Austria | |
| Leczenie farmakologiczne stwardnienia rozsianego | od $3,000 / 102,000฿ | od $2,500 / 85,000฿ | od $2,000 / 68,000฿ |
| Ocrevus (okrelizumab) | od $20,000 / 680,000฿ | od $10,000 / 340,000฿ | od $35,000 / 1,190,000฿ |
Państwo nie płacą za usługi Bookimed. Ceny na leczenie farmakologiczne stwardnienia rozsianego na stronie odpowiadają cennikowi kliniki. Płatność dokonywana jest bezpośrednio w klinice po przyjeździe. Dostępna jest płatność w ratach.
Bookimed dba o Państwa bezpieczeństwo. Współpracujemy tylko z klinikami spełniającymi wysokie międzynarodowe standardy w przeprowadzaniu leczenia farmakologicznego stwardnienia rozsianego. Posiadają one wymagane licencje do obsługi pacjentów międzynarodowych na całym świecie.
Bookimed oferuje bezpłatną pomoc i wsparcie. Osobisty koordynator medyczny pozostaje w kontakcie przed, w trakcie i po podróży. Nie będą Państwo sami w innym kraju podczas procedury Leczenie farmakologiczne stwardnienia rozsianego.
Day 1
Day 2
Day 3
Day 4 to Day 14
Week 3
Week 4
Week 5
Note: Each patient"s journey with multiple sclerosis differs. This plan is a general guideline and may be adjusted based on individual needs.
Dr. Siriporn Cheawchanwej is an aesthetic and anti-aging physician. She holds a Diploma in Aesthetic Medicine from the American Academy of Aesthetic Medicine and completed advanced training at the School of Anti-Aging and Regenerative Medicine and in Facial Design at Mae Fah Luang University.
Her international training includes Restylane seminars in Sweden (2006–2008) and the International Symposium of Botulinum Toxin in Korea. She also attended the Asia Pacific Rhinoplasty Expert Forum in Seoul, the International Congress of Minimal Invasive Plastic Surgery & Dermatology in Seoul, and IMCAS Asia 2009.
Common multiple sclerosis medications in Thailand include disease-modifying therapies like Interferon beta-1a and fingolimod. Patients access high-efficacy infusions such as ocrelizumab and rituximab at major neurological centers. Private hospitals in Bangkok and Phuket provide oral options, injectables, and specialized supportive care like cannabis extracts for spasticity.
Bookimed Expert Insight: While top centers like Bumrungrad International Hospital offer the latest biologics, costs vary significantly by sourcing. Patients often save by using Indian generics for fingolimod. These can reduce monthly expenses to approximately 20,000 THB. Always confirm if your clinic allows pharmacy-sourced medications versus in-house stock.
Patient Consensus: Many patients find that while high-end drugs require long insurance approval wait times, generics from India are well-tolerated and more accessible. Navigating the import process through specialized pharmacies in Singapore is a common strategy for aggressive MS cases.
Multiple sclerosis symptoms like muscle stiffness, or spasticity, are effectively managed in Thailand through specialized medications and physical therapies. Modern neurological centers like Bumrungrad International Hospital utilize oral relaxants, Botox injections, and advanced cellular therapies to reduce painful spasms and improve patient mobility.
Bookimed Expert Insight: While many seek the latest biologics, Thailand differentiates itself through integrated regenerative approaches. Clinics like The Demarest Clinic use AABB-certified protocols and IV therapies alongside traditional meds. This combination often targets systemic inflammation rather than just suppressing isolated muscle symptoms.
Patient Consensus: Patients emphasize that skipping daily stretching makes stiffness dramatically worse. Many find that taking tizanidine at night provides the best relief for spasms without daytime drowsiness.
Patients receive specialized multiple sclerosis treatment in Thailand at JCI-accredited centers like Bumrungrad International Hospital and specialized regenerative clinics in Phuket. These facilities provide advanced diagnostics like 3T MRI, disease-modifying therapies, and innovative mesenchymal stem cell protocols for neuro-inflammation management.
Bookimed Expert Insight: While Thailand is famous for stem cells, its diagnostic infrastructure is the true highlight. Clinics like Bumrungrad serve over 500,000 international patients annually. This massive volume ensures neurologists see rare MS variants more frequently than many Western specialists. This experience often leads to more precise long-term medication adjustments.
Patient Consensus: Patients emphasize securing local prescriptions at Bangkok hospitals for easier medication imports. They recommend maintaining a telehealth link with home specialists to coordinate complex infusion schedules while abroad.
Stem cell therapy is a regulated option for MS in Thailand, primarily utilizing Mesenchymal Stem Cells (MSCs). While the Thai Food and Drug Administration (TFDA) oversees these treatments, they are often used as supportive regenerative care alongside standard disease-modifying therapies in Bangkok and Phuket clinics.
Bookimed Expert Insight: While many private clinics focus on UC-MSC infusions, high-volume centers like Bumrungrad International Hospital serve 1,000,000 patients annually by integrating advanced neurology with regenerative options. Choosing a hospital with JCI and GHA credentials ensures international safety standards that smaller, boutique stem cell clinics may not provide.
Patient Consensus: Patients emphasize the need for transparency regarding long-term results and suggest consulting a home neurologist before traveling. Many recommend verifying if clinic claims are backed by entries in clinical trial registries or PubMed.